Clinical Trials

Cyclic vomiting syndrome

Displaying 2 studies

A Study to Evaluate AZ-010 to Treat Moderate-to-Severe Cyclic Vomiting Syndrome Rochester, MN

The purpose of this study is to assess the effectiveness of AZ-010 as an acute treatment for moderate to severe cyclic vomiting syndrome (CVS) in adult patients, and the safety of AZ-010 in adult patients with moderate-to-severe cyclic vomiting syndrome (CVS).
A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders Rochester, MN

The purpose of this study is to:
1. To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.
2. To assess the impact of PGx testing on prescriber patterns in this practice.
3. To explore the impact of PGx testing on patient outcomes after an assessment in this practice.